-
Does Biogen's Lower P/E Ratio Make It a Better Buy Than Celgene?
Post on 7/18/16
-
12 Reasons to Buy Johnson & Johnson and Never Sell
Post on 7/18/16
-
5 Figures to Look For When Johnson & Johnson Reports Its Second-Quarter Results
Post on 7/18/16
-
Outlaw Training and Fitness Owner Geoffrey Wade Invited Guest Trainer at NFL Performance Training Camp
Post on 7/17/16
-
How Much Do Stock Prices Matter in Biotech?
Post on 7/15/16
-
Fusion Gyms Announces Their Newest Location 2801 Grant Avenue, Philadelphia
Post on 7/14/16
-
Free Health Screenings For New Brunswick Residents on Saturday, July 23rd
Post on 7/14/16
-
5 Things Celldex Therapeutics, Inc. Wants You to Know
Post on 7/14/16
-
Better Buy: Exact Sciences Corporation vs. Quest Diagnostics
Post on 7/14/16
-
Teva Pharmaceutical's (TEVA) Erez Vigodman on 2016-2019 Preliminary Financial Outlook (Transcript)
Post on 7/14/16
-
GlaxoSmithKline: Brexit's Hit To GBP May Help Sustain Yield
Post on 7/14/16
-
Cure Breast Cancer Foundation Raises Over $500,000 With Two Spring/Summer Events
Post on 7/13/16
-
Holy Redeemer Welcomes New Surgeon Dr. Patricia Leung Joins Holy Redeemer Surgical Associates
Post on 7/13/16
-
Which Pipeline Has Better Potential: Celgene or Biogen?
Post on 7/13/16
-
Merck Continues To Turn Heads
Post on 7/13/16
-
Deborah Heart and Lung Center Joins AmeriHealth New Jersey’s Growing List of Tier 1 Providers
Post on 7/12/16
-
Hemispherx Updates the Status of the Alferon Manufacturing Facility
Post on 7/11/16
-
Ogilvy CommonHealth Worldwide Poised to Win Big at MM&M Awards
Post on 7/11/16
-
Merck’s Healthcare Services & Solutions Invests in Majority Stake in StayWell
Post on 7/11/16
-
Echo Therapeutics Common Stock to Transition from NASDAQ to OTCQB
Post on 7/10/16
-
Pharmacy Times Ranks No. 1 Among Pharmacists in Average Issue Readership and Ad Page Exposures
Post on 7/10/16
-
The Big Reason Behind Celgene Corporation's 13% Year-to-Date Tumble
Post on 7/8/16
-
At Johns Hopkins, Christy Wyskiel Helps Bring Innovative Products to Market
Post on 7/7/16
-
Pernix Therapeutics Announces Restructuring of Sales Force and Operations
Post on 7/7/16
-
Teligent Advances $50 Million Facility Expansion
Post on 7/6/16
Philadelphia
